期刊文献+

异基因造血干细胞移植后偏肺病毒合并巨细胞病毒感染1例 被引量:1

Human metapneumovirus and cytomegalovirus coinfection in an ailogeneic hematopoietic stem cell transplant recipient one case
原文传递
导出
摘要 目的报道1例急性非淋巴细胞白血病患者异基因造血干细胞移植后发生巨细胞病毒(cMV)合并偏肺病毒(hMPV)感染病例,并监测其hMPV排毒时间。方法定期采集患者咽拭子和痰样本,采用实时荧光定量聚合酶链反应的方法测定样本中hMPV的拷贝数。结果该患者的咽拭子和痰中hMPV持续阳性至发病后第41天。结论免疫功能低下患者感染hMPV可长期无症状排毒,临床医生需要给予动态监测,并做好预防院内感染的措施。 Objective To report the occurrence of lower respiratory tract disease associated with cytomegalovirus and hMPVcoinfection in a patient after allogeneic hematopoietic stem cell transplantation (HSCT) for acute non-lymphocytic leukemia, and to monitor the shedding time of hMPV. Methods Patient's oropharyngeal swab and sputum samples periodically were collected, hMPV copies in these sampes were determined by real-time polymerase chain reaction. Results Repeat oropharyngeal swab and sputum samples was positive for hMPV until 41th day after onset. Conclusions Immunocompromised patients infected with hMPV will show as prolong viral shedding with asymptomatic and the clinician must pay more attention on immunocompromised patients for viral shedding, and prevent cross infection in the ward.
出处 《国际呼吸杂志》 2015年第18期1394-1396,共3页 International Journal of Respiration
基金 国家科技支持计划(2012BA105B01) 广东省省级科技计划(20138020224006) 广州市科技计划项目一广州市健康医疗协同创新重大专项(201400000002)
关键词 异基因造血干细胞移植 偏肺病毒 巨细胞病毒 Allogeneic hematopoietic stem cell transplant Human metapneumovirus Cytomegalovirus
  • 相关文献

参考文献11

  • 1Al Hajjar SI, Al Thawadi S, Al Seraihi A, et al. Humanmetapneumovirus and human coronavirus infection andpathogenicity in Saudi children hospitalized with acuterespiratory illness[J]. Ann Saudi Med,2011,31(5) :523-527.
  • 2Debiaggi M, Canducci F,Sampaolo M,et al. Persistentsymptomless human metapneumovirus infection inhematopoietic stem cell transplant recipients[J]. J Infect Dis,2006,194(4):474-478.
  • 3Oliveira R,Machado A,Tateno A,et al. Frequency of humanmetapneumovirus infection in hematopoietic SCT recipientsduring 3consecutive years. [ J ] Bone Marrow Transplant,2008,42C4):265-269.
  • 4Cane PA,van den Hoogen BG, Chakrabarti S, et al. Humanmetapneumovirus in a haematopoietic stem cell transplantrecipient with fatal lower respiratory tract disease[J]. BoneMarrow Transplant,2003 ,31(4) : 309-310.
  • 5徐春浩,梁辉.干细胞移植后的巨细胞病毒感染[J].中国组织工程研究与临床康复,2007,11(42):8549-8552. 被引量:2
  • 6Nichols WG,Corey L,Gooley T,et al. High risk of death dueto bacterial and fungal infection among cytomegalovirus(CMV)-seronegative recipients of stem cell transplants fromseropositive donors: evidence for indirect effects of primaryCMV infection[J]. J Infect Dis,2002,185(3) : 273-282.
  • 7Dokos C, Masjosthusmann K, Rellensmann G,et al. Fatalhuman metapneumovirus infection following allogeneichematopoietic stem cell transplantation [ J ]. Transpl InfectDis,2013,15(3) :E97-E101.
  • 8Peng D,Zhao X,Liu E,et al. Analysis of viral load in childreninfected with human metapneumovirus [ J]. Iran J Pediatr,2010,20(4):393-400.
  • 9Kamboj M,Gerbin M, Huang CK, et al. Clinicalcharacterization of human metapneumovirus infection amongpatients with cancer[J], J Infect,2008,57(6) :464-471.
  • 10Tomaszewska Al, Krysko A, Dziecia^tkowski T, et al. Co-infections with cytomegalovirus and human herpesvirus type7 in adult Polish allogeneic haematopoietic stemcell transplantrecipients[J]. Arch Immunol Ther Exp (Warsz), 2014, 62(1):77-80.

二级参考文献35

  • 1Ljungman P,Aschan J,Lewensohn-Fuchs I,et al.Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients.Transplantation 1998;66(10):1330-1334
  • 2Ljungman P,Larsson K,Kumlien G,et al.Leukocyte depleted,unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donors.Scand J Infect Dis 2002;34(5):347-350
  • 3Nichols WG,Corey L,Gooley T,et al.High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors:evidence for indirect effects of primary CMV infection.J Infect Dis 2002;185(3):273-282
  • 4Hambach L,Stadler M,Dammann E,et al.lncreased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation.Bone Marrow Transplant 2002;29(11):903-906
  • 5Broers AE,van Der Holt R,van Esser JW,et al.Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation.Blood 2000;95(7):2240-2245
  • 6Bowden RA,SIichter SJ,Sayers MH,et al.Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant Blood 1991;78(1):246-250
  • 7Kiehl MG,Basara N.Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.Blood 2001;98(5):1626-1628
  • 8Bacigalupo A,Bregante S,Tedone E,et al.Combined foscamet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (Hsct).Transplantation 1996;62(3):376-380
  • 9Mattes FM,Hainsworth E,Murdin-Geretti AM,et al.A randomized,controlled trial comparing ganciclovir or ganciclovir plus foscarner(each half dose)for pre-emptive therapy of cytomegalovirus infection in transplant recipients.Presented at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy,Chicago,lllinois,2001
  • 10Kline J,Pollyea DA,Stock W,et al.Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.Bone Marrow Transplant 2006;37(3):307-310

共引文献1

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部